Susquehanna Fundamental Investments’s AtriCure ATRC Stock Holding History

Susquehanna Fundamental Investments’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.41M	Buy	+50,484	New	+$1.42M	0.03%	408
2025 Q4	–	Sell	-75,922	Closed	-$2.68M	–	567
2025 Q3	$2.68M	Sell	75,922 -16,714	-18%	-$576K	0.1%	206
2025 Q2	$3.04M	Sell	92,636 -17,705	-16%	-$575K	0.08%	267
2025 Q1	$3.56M	Buy	110,341 +6,247	+6%	+$232K	0.05%	392
2024 Q4	$3.18M	Buy	+104,094	New	+$3.35M	0.05%	424

Other funds holding ATRC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Susquehanna Fundamental Investments's ATRC Position: Q2 2026 in Review

Susquehanna Fundamental Investments opened a new position in AtriCure (ATRC) in Q2 2026: 50,484 shares worth $1.41M. The stake represents 0.03% of the portfolio and ranks #408 among its holdings. This is a return to the name: Susquehanna Fundamental Investments previously reported a position in ATRC as recently as Q3 2025.

Susquehanna Fundamental Investments first reported a position in ATRC in Q4 2024 and has held it in 5 quarters since. The position peaked at $3.56M in Q1 2025. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

Susquehanna Fundamental Investments held 50,484 shares of AtriCure worth $1.41M as of Q2 2026.
AtriCure was a new Susquehanna Fundamental Investments position in Q2 2026.
AtriCure made up 0.03% of Susquehanna Fundamental Investments's portfolio in Q2 2026, its #408 holding.
Susquehanna Fundamental Investments first reported a position in AtriCure in Q4 2024 and has held it in 5 quarters since.
Susquehanna Fundamental Investments's AtriCure position peaked at $3.56M in Q1 2025.
251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2026, filed 14 Aug 2026.